RecombinantCCL2(MCP-1)
CatalogNo.Size
50186P-22ug
50186P-1010ug
50186P-5050ug
50186P-100100ug
50186P-10001000ug
CCL2,alsoknownasMonocyteChemoattractantProtein-1(MCP-1)isasmallcytokine(~13kDa)thatbelongstotheCCchemokinefamily.CCL2recruitsmonocytes,memoryTcells,anddendriticcellstositesofinflammationproducedbyeithertissueinjuryorinfection.Itisanchoredintheplasmamembraneofendothelialcellsbyglycosaminoglycansidechainsofproteoglycans.Tobecomeactivated,CCL2proteinhastobecleavedbymetalloproteinaseMMP-12.CCL2isimplicatedinthepathogenesisofseveraldiseasescharacterizedbymonocyticinfiltrates,suchaspsoriasis,rheumatoidarthritisandatherosclerosis.CCR2andCCR4aretwocellsurfacereceptorsthatbindCCL2.
Source:RecombinanthumanCCL2isproducedinE.coli(accessionno.
P13500).
ProteinSequence:QPDAINAPVTCCYNFTNRKISVQRLASYRRITSSKCPKEAVIFKTIVAKEICADPKQKWVQDSIDHLDKQTQTPKT
MolecularMass:8.662kDabyMassSpec.
Purity:>97%bySDS-PAGE
Activity:EC50=0.067nMdeterminedbymigrationorrecombinantCCR2-expressingcells.
EndotoxinLevel:<0.01EUper1ugofproteinbyLALmethod.
Form:Lyophilized.
CarrierProtein:None.
Reconstitution:Recommendedat100ug/mlinsteriledistilledwater.
StABIlityandStorage:12monthsfromdateofreceipt,-20oCto-70oC,assupplied.
1month,2oCto8oC,understerileconditionsafterreconstitution.
3months,-20oCto-70oC,understerileconditionsafterreconstitution.
Forinvitroinvestigationaluseonly.Notforuseindiagnosticortherapeuticprocedures.